Sensorimotor deficits and increased brain nicotinic acetylcholine receptors following exposure to chlorpyrifos and/or nicotine in rats.
Despite well-known adverse effects associated with cigarette smoking, approximately 20% of the US population continues to smoke and many more are exposed to environmental tobacco smoke. Many of the same individuals are also exposed to environmental neurotoxic chemicals such as the organophosphorus insecticide chlorpyrifos. In the present study, the effects of exposure to low doses of nicotine and chlorpyrifos alone and in combination, were studied on the central cholinergic system and sensorimotor performance in rats. Male Sprague-Dawley rats (250-300 g) were treated with nicotine (1 mg/kg s.c., in normal saline), chlorpyrifos (0.1 mg/kg dermally, in 0.1 ml 70% ethanol), or a combination of both, daily for 30 days. Control rats were treated with saline and dermally with ethanol. Sensorimotor behavior was evaluated 24 h following the last dose using a battery of tests. There was a significant deficit in incline plane performance, beam-walk score and beam-walk time following exposure to each chemical, alone or in combination. The deficit in incline plane performance was greater when the two chemicals were given in combination than with either compound alone. Biochemical analysis showed a decrease in cerebellar and an increase in midbrain acetylcholinesterase (AChE) activity following combined exposure. Exposure to nicotine alone resulted in a significant increase in AChE activity in brainstem and midbrain, whereas there was no significant change after exposure to chlorpyrifos, alone. A significant increase in ligand binding to nicotinic acetylcholine receptors (nAChR) was observed in brainstem and cortex following exposure to nicotine or chlorpyrifos. This was further augmented with combined exposure, which caused a modest but significant increase in m2 muscarinic acetylcholine receptors (m2-mAChR) ligand binding in the cortex. These data suggest that exposure to either nicotine or chlorpyrifos or a combination of the two may impair neurobehavioral performance and affect the central nervous system cholinergic pathways.
Abou-Donia
Mohamed B
MB
Department of Pharmacology and Cancer Biology, Duke University Medical Center, Durham, NC 27710, USA. donia@acpub.duke.edu
Abdel-Rahman
Ali
A
Goldstein
Larry B
LB
Dechkovskaia
Anjelika M
AM
Shah
Deepti U
DU
Bullman
Sarah L
SL
Khan
Wasiuddin A
WA
D000109:Acetylcholine / Q000378:metabolism; D000818:Animals; D001522:Behavior, Animal / Q000187:drug effects*; D001921:Brain / Q000187:drug effects / Q000378:metabolism / Q000502:physiology; D002491:Central Nervous System Agents / Q000633:toxicity*; D004390:Chlorpyrifos / Q000633:toxicity*; D002802:Cholinesterases / Q000378:metabolism; D004347:Drug Interactions; D007306:Insecticides / Q000633:toxicity*; D008024:Ligands; D008297:Male; D009043:Motor Activity / Q000187:drug effects; D009538:Nicotine / Q000633:toxicity*; D051381:Rats; D017207:Rats, Sprague-Dawley; D043585:Receptor, Muscarinic M2 / Q000187:drug effects / Q000378:metabolism; D011978:Receptors, Nicotinic / Q000187:drug effects* / Q000378:metabolism
D002491:Central Nervous System Agents; D007306:Insecticides; D008024:Ligands; D043585:Receptor, Muscarinic M2; D011978:Receptors, Nicotinic; D009538:Nicotine; D002802:Cholinesterases; D004390:Chlorpyrifos; D000109:Acetylcholine